Scholarly Index
Olivier Trédan
Centre de Recherche en Cancérologie de Lyon; 17,076 total citations; 463 total publications; best world rank #117
Centre de Recherche en Cancérologie de Lyon
17,076Total citations
463Total publications
55H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| HER2/EGFR in Cancer Research | Lifetime | 925 | FR 46 | 96.35 |
| Advanced Breast Cancer Therapies | Lifetime | 523 | FR 30 | 95.91 |
| PARP inhibition in cancer therapy | Lifetime | 636 | FR 32 | 93.36 |
| Cancer Treatment and Pharmacology | 2021-2025 | 117 | FR 13 | 97.67 |
| Breast Cancer Treatment Studies | 2021-2025 | 330 | FR 20 | 96.33 |
| PARP inhibition in cancer therapy | 2021-2025 | 150 | FR 14 | 94.77 |
| Advanced Breast Cancer Therapies | 2021-2025 | 247 | FR 19 | 95.71 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 413 | FR 21 | 94.34 |
| HER2/EGFR in Cancer Research | 2021-2025 | 508 | FR 30 | 91.70 |
| BRCA gene mutations in cancer | 2021-2025 | 653 | FR 12 | 85.79 |
| Cancer-related Molecular Pathways | 2021-2025 | 776 | FR 18 | 74.74 |
| Estrogen and related hormone effects | 2021-2025 | 864 | FR 35 | 72.15 |
| Cancer-related cognitive impairment studies | 2021-2025 | 974 | FR 29 | 64.19 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 1,000 | FR 20 | 54.45 |